NASDAQ:KNTE

Kinnate Biopharma Earning Date

USA |NASDAQ |USD

KNTE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
- Sep 30, 2021 - $-0.49 -
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
- Sep 30, 2021 - $0.00 $0.00

KNTE Earnings Date & History Chart

KNTE Earnings & Revenue Forecast

KNTE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-0.64 $-0.99 $-0.51
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-2.01 $-2.43 $-1.49
Dec 2022 7 $-2.38 $-3.40 $-1.38

KNTE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.59 $-0.55 $-0.55
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-2.02 $-1.88 $-1.88
Dec 2022 1 / 0 $-2.57 $-2.56 $-2.56

KNTE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $0.00 $0.00 $0.00
Dec 2022 7 $0.00 $0.00 $0.00

KNTE Earnings Date & Revenue History

KNTE Earnings History

|
Show More
Show More

KNTE Revenue History

|
Show More
Show More

Kinnate Biopharma Next Earnings Date & Report

KNTE Aug 2021 (FQ) Earnings Date & Report Preview

Kinnate Biopharma Previous Earnings Dates & Reports

KNTE Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Kinnate Biopharma's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

KNTE's earnings per share (EPS) was $-0.49, missing the consensus analysts forecast of $-0.42 by -15.98%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 22.50%.

Revenues were $0.00.

The company reported a net income of $-21.45M.

Free cash flow for the quarter was $-17.49M , compared to $-13.71M last quarter and $-5.81M a year before.

KNTE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Kinnate Biopharma's previous annual earnings date was Mar 29, 2021 for its fiscal year ended Dec 31, 2020.

KNTE's earnings per share (EPS) was $-1.19.

Revenues were $0.00.

The company reported a net income of $-35.76M.

Kinnate Biopharma reported a free cash flow of $-30.48M for its fiscal year, compared to $-10.53M a year ago.